Medxy AI

Acoramidis and Kidney Function in Transthyretin Amyloid Cardiomyopathy: Clinical Implications and Hemodynamic Insights

By MedXY 07/03/2026

Acoramidis stabilizes transthyretin and shows kidney-protective effects in transthyretin amyloid cardiomyopathy by reducing eGFR decline and albuminuria, with an initial reversible dip in kidney function associated with improved clinical outcomes.

Cardiology Clinical Updates news

Economic Impact and Clinical Benefits of Quadruple Guideline-Directed Medical Therapy in Heart Failure with Reduced Ejection Fraction: A Comprehensive Review

By MedXY 07/03/2026

This review synthesizes evidence demonstrating that implementing full quadruple GDMT (ARNI, β-blockers, MRAs, SGLT2i) in HFrEF reduces hospitalization risks and healthcare costs, often yielding net savings despite medication expenses.

Cardiology news Respiratory

Enhancing Risk Prediction After TAVI: The COPD-Augmented R₂CHA₂DS₂-VA Score and Its Prognostic Value

By MedXY 07/03/2026

A novel risk score incorporating COPD and graded renal dysfunction improves prediction of one-year mortality post-TAVI, showing excellent internal validity but requiring external validation before clinical use.

Cardiology Clinical Updates Internal Medicine news

Switching from Warfarin to Direct Oral Anticoagulants in Frail Elderly Asian Patients with Atrial Fibrillation: Insights from a Korean Nationwide Study

By MedXY 07/03/2026

In frail elderly Asian AF patients stable on warfarin, transitioning to DOACs increased risks of bleeding, thromboembolic events, and mortality, emphasizing cautious individualized management.

Cardiology Diabetes & Endocrinology news

Ultra-Thin Sirolimus-Eluting Stents Show Noninferiority to Everolimus-Eluting Stents in Diabetic Multivessel CAD: Insights from TUXEDO-2 Trial

By MedXY 07/02/2026

The TUXEDO-2 trial demonstrated that ultra-thin strut biodegradable polymer sirolimus-eluting stents are noninferior to durable polymer everolimus-eluting stents in diabetic patients with multivessel coronary artery disease at 1-year follow-up.

Cardiology news

Impact of Multidimensional Social Adversity on Mortality and Rehospitalization in People with HIV and Heart Failure

By MedXY 07/02/2026

This study explores how various social adversity domains affect mortality and rehospitalization risks in HIV-positive patients with heart failure, underscoring the importance of holistic social assessments for improving outcomes.

Cardiology Clinical Updates news Radiology

Cardiac Risk After Heart-Sparing Breast Radiotherapy: Emphasis on Left Anterior Descending Artery Dose Metrics

By MedXY 07/02/2026

Emerging evidence indicates that radiation dose to the left anterior descending coronary artery better predicts cardiac events than whole-heart dose in breast radiotherapy, emphasizing the importance of LAD-based planning to reduce long-term cardiac risks.

news Psychiatry Public Health

Efficacy and Safety of Mirtazapine in Treating Methamphetamine Use Disorder: Insights from a Phase 3 Randomized Clinical Trial

By MedXY 07/02/2026

This randomized clinical trial evaluated mirtazapine's safety and efficacy for methamphetamine use disorder, revealing a modest but statistically significant reduction in methamphetamine use without unexpected adverse events, offering a promising pharmacotherapy option for this challenging condition.

Critical Care Infectious Diseases news

Clinical Metagenomics in Sepsis: Insights from the DigiSep Randomized Controlled Trial

By MedXY 07/02/2026

The DigiSep trial assessed the impact of metagenomic next-generation sequencing (mNGS) on sepsis outcomes. While primary endpoint improvement was not significant, secondary analyses revealed benefits in mechanical ventilation duration, shock resolution, and quality of life without raising healthcare costs.

Critical Care Neurology news

AI-Driven Point-of-Care EEG Seizure Burden Monitoring Predicts Clinical Outcomes at Discharge

By MedXY 07/02/2026

AI-enabled point-of-care EEG monitoring accurately measures seizure burden, showing a dose-dependent association with unfavorable clinical outcomes at discharge, highlighting its potential in critical care.

AI Emergency Medicine news

Enhancing End-of-Life Mortality Prediction in Emergency Departments Using Collaborative AI Tools

By MedXY 07/02/2026

A study comparing physician-based surprise question, AI-driven GEST model, and a combined approach shows improved accuracy and efficiency in predicting 6-month mortality among older ED patients.

Diabetes & Endocrinology Internal Medicine news

Enhancing Preventive Screening Uptake: EHR Portal Messages Boost Mammography Rates

By MedXY 07/02/2026

Iterative redesign of electronic health record (EHR) portal reminders significantly improved mammography screening adherence in an outpatient setting, demonstrating the value of concise messages with scheduling links, while retinal and HbA1c reminders showed no effect.

Infectious Diseases news Public Health

Evaluating the Safety of Same-Day COVID-19 and Influenza Vaccination: Insights from a Large Veterans Affairs Target Trial Emulation

By MedXY 07/02/2026

A large U.S. Veterans Affairs study found no increased 90-day risk of adverse events after same-day COVID-19 and influenza vaccination compared to influenza vaccination alone, supporting the safety of coadministration with updated COVID-19 formulations.

Hematology-Oncology news

Decoding Clonal Evolution and Immunophenotype in NPM1-Mutated AML through Single-Cell Multiomics

By MedXY 07/02/2026

Single-cell multiomic analysis reveals how genotype-immunophenotype relationships shape clonal evolution in NPM1-mutated acute myeloid leukemia, highlighting implications for prognosis and therapy response.

news Oncology Respiratory

Symptom Prevalence in Lung Cancer Screening: Insights from the SUMMIT Study

By MedXY 07/02/2026

The SUMMIT study reveals that respiratory symptoms are common among lung cancer screening participants and associated with increased lung cancer diagnosis risk within one year, challenging conventional asymptomatic screening definitions.

news Respiratory

AD109 (Aroxybutynin and Atomoxetine): A Promising Oral Therapy for Obstructive Sleep Apnea in PAP-Intolerant Patients

By MedXY 07/02/2026

The SynAIRgy phase 3 trial demonstrated that the fixed-dose combination of aroxybutynin and atomoxetine (AD109) significantly reduces airway obstruction and improves oxygenation in obstructive sleep apnea patients unable to tolerate positive airway pressure therapy.

news Ophthalmology

Breakthrough Optogenetic Therapy UGX-201 Shows Promise for Advanced Retinitis Pigmentosa

By MedXY 07/02/2026

An exploratory trial of UGX-201, a novel optogenetic therapy, demonstrated safety and meaningful visual improvements in patients with advanced nonsyndromic retinitis pigmentosa, including restoration of light perception in those previously without vision.

Clinical Updates news

Neuroretinal Layer Thinning on OCT Imaging and Hemoglobin A1c in Youth With Type 1 Diabetes: Emerging Insights and Clinical Implications

By MedXY 07/02/2026

This review synthesizes evidence linking neuroretinal layer thinning observed by OCT with glycemic control and diabetic retinal disease in youth with type 1 diabetes, emphasizing early neurodegeneration preceding vascular changes and its potential as a biomarker.

news Ophthalmology

Avacincaptad Pegol Demonstrates Efficacy in Slowing Photoreceptor Loss in Geographic Atrophy via Ellipsoid Zone Preservation

By MedXY 07/02/2026

Avacincaptad pegol significantly reduces progression of ellipsoid zone degradation and geographic atrophy lesion growth, highlighting its potential to preserve photoreceptor integrity in AMD patients.

Clinical Updates news Otorhinolaryngology Radiology

Addressing Barriers and Enhancing Facilitators of Timely Postoperative Radiotherapy for Head and Neck Cancer in Rural Communities: A Clinical Review

By MedXY 07/02/2026

This review synthesizes evidence on factors influencing delays in postoperative radiotherapy for head and neck cancer in rural settings, emphasizing communication, coordination, and community resources to inform strategies that improve care equity and outcomes.